Publisher Correction: Clinical efficacy and biomarker analysis of neoadjuvant atezolizumab in operable urothelial carcinoma in the ABACUS trial (Nature Medicine, (2019), 25, 11, (1706-1714), 10.1038/s41591-019-0628-7)
- Powles, Thomas
- Kockx, Mark
- Rodriguez-Vida, Alejo
- Duran, Ignacio
- Crabb, Simon J.
- van der Heijden, Michiel S.
- Szabados, Bernadett
- Pous, Albert Font
- Gravis, Gwenaelle
- Herranz, Urbano Anido
- Protheroe, Andrew
- Ravaud, Alain
- Maillet, Denis
- Mendez, Maria Jose
- Suarez, Cristina
- Linch, Mark
- Prendergast, Aaron
- van Dam, Pieter-Jan
- Stanoeva, Diana
- Daelemans, Sofie
- Mariathasan, Sanjeev
- Tea, Joy S.
- Mousa, Kelly
- Banchereau, Romain
- Castellano, Daniel
Publication date
June 2020
DOI Publisher
Springer Science and Business Media LLCAbstract
In the version of this article initially published, the labels in the key to Fig. 1f (red bars, Down in responders; blue bars, Up in responders) were incorrect. The correct labels are as follows: red bars, Up in responders; blue bars, Down in responders. Also, the histopathology images in Fig. 2a were incorrect. The correct images are now provided. The errors have been corrected in the HTML and PDF versions of the article
Add to ORKG